NCT05610306

Brief Summary

The goal of this observational study is to learn about the quality of life in patients with congenital ichthyosis. The main question it aims to answer are: • What is the impact of ichthyosis on the biological-psychological-social quality of life in adult and elderly patients with inherited ichthyosis ? Participants will take part in individual interviews in which the investigators will explore if and how ichthyosis impacts their quality of life. Examples of such questions are whether participants experience pain, experience struggles in their personal or professional lives, with sports activities or if participants experience a financial burden.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 2, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 9, 2022

Completed
5 days until next milestone

Study Start

First participant enrolled

November 14, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2023

Completed
Last Updated

October 1, 2025

Status Verified

November 1, 2024

Enrollment Period

9 months

First QC Date

November 2, 2022

Last Update Submit

September 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Quality of life assessment

    Qualitative evaluation of quality of life by interviews of patients with inherited ichthyosis.

    1 day

Study Arms (1)

Inherited ichthyosis patients

Interviews

Other: Qualitative interview

Interventions

Qualitative interviews to gain insight into the impact of ichthyosis on the biological, psychological, and social quality of life in adult and elderly patients.

Inherited ichthyosis patients

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who are diagnosed with congenital ichthyosis

You may qualify if:

  • years of age and older
  • Clinical or genetic confirmed variant of congenital ichthyosis

You may not qualify if:

  • \<30 years of age
  • ichthyosis vulgaris
  • another primary chronic skin condition besides ichthyosis
  • patients who are not able to read/speak Dutch

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maastricht University Medical Centre +

Maastricht, 6229HX, Netherlands

Location

MeSH Terms

Conditions

Ichthyosis Vulgaris

Condition Hierarchy (Ancestors)

IchthyosisSkin AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSkin Diseases, GeneticGenetic Diseases, InbornKeratosisSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Antoni H Gostynski, MD, PhD

    MAASTRICHT UMC+

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 2, 2022

First Posted

November 9, 2022

Study Start

November 14, 2022

Primary Completion

July 31, 2023

Study Completion

July 31, 2023

Last Updated

October 1, 2025

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will share

The interview protocol of the qualitative study. Supplementary Table with patient demographics.

Shared Documents
STUDY PROTOCOL, ANALYTIC CODE
Time Frame
From 22-10-2024 onwards, no end date.
Access Criteria
Everyone who accesses the ClinicalTrials.gov website will be able to view the individual participant data (IPD) and supporting information associated with the study.

Locations